|
시장보고서
상품코드
2078384
진드기 매개 뇌염 시장 : 시장 규모, 점유율, 성장 분석 - 제품별, 용도별, 유통 경로별, 최종 사용자별, 지역별 업계 예측(2026-2033년)Tick Borne Encephalitis Market Size, Share, and Growth Analysis, By Product (Vaccines, Immunoglobulins ), By Application, By Distribution, By End-User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 진드기 매개 뇌염 시장 규모는 2024년에 3억 8,250만 달러로 평가되었고, 2025년 4억 782만 달러에서 2033년까지 6억 8,240만 달러로 확대될 전망이며, 예측 기간(2026-2033년) CAGR 6.62%로 성장할 전망입니다.
세계의 진드기 매개 뇌염(TBE) 시장에는 이크소데스속 진드기에 의해 매개되는 이 바이러스 감염증에 대항하기 위해 개발된 다양한 백신, 진단 도구 및 치료제가 마련되어 있습니다. 기후 변화로 인해 진드기의 서식지와 인간의 노출 상황이 변화함에 따라, 유럽과 아시아에서 TBE 사례가 증가하고 있어 이 시장의 중요성이 커지고 있습니다. 이전에는 지리적 범위가 제한적이었으나, 주요 지역에서 유행이 확산되면서 경제적 부담이 부각됨에 따라 백신 사용이 급증하고 있습니다. 이를 통해 생명공학 분야에 대한 투자가 유치되면서, 혁신적인 백신 개발이 진행되고 있습니다. 백신 접종을 장려하기 위한 정부의 이니셔티브도 수요를 더욱 촉진하고 있으며, 이는 생산 효율 향상과 비용 절감으로 이어지고 있습니다. 또한, AI를 활용한 연구 개발의 진전으로 백신 개발 과정이 가속화되면서, 변이된 바이러스 균주에 신속하게 대응할 수 있게 되었고, 전 세계 위험군 대상의 예방접종 전략 전반이 개선되고 있습니다.
세계 진드기 매개 뇌염 시장의 성장 요인
진드기 매개 질환의 유병률 증가로 인해 보건 당국이 효과적인 예방 전략의 필요성을 강조하고 있는 가운데, 이는 전 세계 진드기 매개 뇌염 시장의 성장을 크게 견인하고 있습니다. 이러한 집중적인 노력으로 인해 백신 및 예방적 치료에 대한 수요가 현저히 증가하고 있습니다. 또한, 의료 종사자들의 인식 제고를 통해 조기 발견이 개선되고, 백신 접종 노력이 촉진되고 있습니다. 그 결과, 의료 서비스 제공업체들은 예방접종 캠페인에 투자하고 유통망을 강화하고 있으며, 제조업체들에게도 생산 능력 향상을 촉구하고 있습니다. 이러한 추세는 질병 부담 증가가 해당 분야의 추가적인 투자, 연구 및 상업 활동을 촉진하는 선순환을 만들어내고 있습니다.
세계 진드기 매개 뇌염 시장의 제약 요인
세계의 진드기 매개 뇌염 시장의 성장은 백신 공급이 제한적이라는 점 때문에 저해되고 있습니다. 이로 인해 공급 부족이 발생하고 있으며, 특히 수요가 생산 능력을 초과하는 유행 지역에서는 효과적인 예방접종 활동이 저해되고 있습니다. 보건 당국은 고위험군에 충분한 백신을 확보하는 데 어려움을 겪고 있으며, 그 결과 우선순위 결정 전략이 자주 채택되면서 저위험군이 백신 접종을 받지 못하는 상황이 발생하고 있습니다. 이러한 공급 제한으로 인해 전반적인 백신 접종률이 낮아지고, 예방 조치가 약화되면서 질병의 확산이 계속되고 있습니다. 게다가 제조업체들은 생산 확대 압박에 시달리고 있지만, 규제 및 물류상의 문제로 인해 확대가 지연되면서 공급 부족을 더욱 악화시키고, 시장 성장을 둔화시키고 있습니다.
세계의 진드기 매개 뇌염 시장 동향
세계의 진드기 매개 뇌염 시장은 기후 변화로 인한 진드기 서식지 확대를 배경으로 역동적인 변화를 겪고 있습니다. 기온 상승과 강수 패턴의 변화로 인해, 이러한 매개 생물들이 저위험 지역으로 침입할 수 있게 되었기 때문입니다. 동시에, 농촌 지역이나 산림 지대에서의 레크리에이션 활동이 증가함에 따라, 인간이 진드기에 노출될 기회도 늘어나고 있습니다. 이러한 요인들이 복합적으로 작용하여 보고되는 사례 수가 현저히 증가하고 있으며, 의료 종사자들 사이에서 이에 대한 인식이 높아지고, 공중보건 차원의 대응이 촉진되고 있습니다. 그 결과, 예방책에 대한 수요가 증가하고 있으며, 시장 관계자들은 감시 체계를 강화하고, 제품 라인업을 최적화하며, 새로운 유행 지역에서 대상층을 좁혀 집중적인 계몽 프로그램을 실시해야 하는 상황에 직면해 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학 및 전망
주요 시장 인사이트
세계의 진드기 매개 뇌염 시장 규모 : 제품별
세계의 진드기 매개 뇌염 시장 규모 : 용도별
세계의 진드기 매개 뇌염 시장 규모 : 유통 경로별
세계의 진드기 매개 뇌염 시장 규모 : 최종 사용자별
세계의 진드기 매개 뇌염 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론 및 제안
AJY 26.07.13Global Tick Borne Encephalitis Market size was valued at USD 382.5 Million in 2024 and is poised to grow from USD 407.82 Million in 2025 to USD 682.4 Million by 2033, growing at a CAGR of 6.62% during the forecast period (2026-2033).
The global Tick-Borne Encephalitis (TBE) market features a comprehensive range of vaccines, diagnostic tools, and therapeutics designed to combat this viral infection spread by Ixodes ticks. The market's significance is rising due to increased TBE cases in Europe and Asia, driven by climate change that alters tick habitats and human exposure. While previously limited in geographic scope, the surge in vaccine use is attributed to recognized economic burdens following outbreaks in key regions, attracting biotech investment and leading to innovative vaccine development. Government initiatives promoting vaccination have further stimulated demand, enhancing production efficiency and lowering costs. Additionally, advancements in AI-driven research are expediting vaccine development processes, enabling quicker adaptation to evolving strains and improving overall immunization strategies within at-risk populations globally.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tick Borne Encephalitis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Tick Borne Encephalitis Market Segments Analysis
Global tick borne encephalitis market is segmented by product, application, distribution, end-user and region. Based on product, the market is segmented into Vaccines and Immunoglobulins (Supportive). Based on application, the market is segmented into Pre-Exposure Vaccination and Post-Exposure Prophylaxis. Based on distribution, the market is segmented into Government Immunization Programs, Travel Clinics and Hospital Pharmacies. Based on end-user, the market is segmented into High-Risk Occupational Groups and Travelers to Endemic Areas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Tick Borne Encephalitis Market
The increasing prevalence of tick-borne diseases significantly propels the growth of the global Tick Borne Encephalitis market, as health authorities emphasize the need for effective prevention strategies. This focus results in a marked rise in the demand for vaccines and prophylactic treatments. In addition, a higher level of awareness among healthcare professionals leads to improved early detection and promotes vaccination initiatives. As a result, healthcare providers are investing in immunization campaigns, bolstering distribution networks and prompting manufacturers to enhance their production capabilities. This dynamic fosters a cycle where the mounting burden of disease stimulates further investment, research, and commercial activity within the sector.
Restraints in the Global Tick Borne Encephalitis Market
The growth of the Global Tick Borne Encephalitis market is hindered by the limited availability of vaccines, which leads to supply shortages and hampers effective immunization efforts, particularly in endemic areas where demand exceeds production capabilities. Health authorities face difficulties in obtaining enough doses for high-risk populations, resulting in prioritization strategies that often leave lower-risk groups without access to vaccination. This restricted availability lowers overall vaccination rates, thereby weakening preventive measures and allowing disease transmission to continue. Additionally, manufacturers are under pressure to increase production, but regulatory and logistical challenges delay expansion, further exacerbating supply limitations and slowing market progress.
Market Trends of the Global Tick Borne Encephalitis Market
The Global Tick Borne Encephalitis market is witnessing a dynamic shift driven by the expanding habitats of ticks due to climate change, as warmer temperatures and altered precipitation patterns allow these vectors to infiltrate low-risk regions. Concurrently, increased recreational activities in rural and forested areas elevate human exposure levels. This convergence has led to a noticeable rise in reported cases, heightening awareness among healthcare professionals and prompting public health initiatives. As a result, there is a growing demand for preventative solutions, compelling market players to enhance surveillance, tailor their product offerings, and implement targeted outreach programs in emerging endemic areas.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Tick Borne Encephalitis Market Size by Product & CAGR (2026-2033)
- Market Overview
- Vaccines
- FSME-Immun (Pfizer)
- Encepur (GSK/Bavarian Nordic)
- Immunoglobulins (Supportive)
Global Tick Borne Encephalitis Market Size by Application & CAGR (2026-2033)
- Market Overview
- Pre-Exposure Vaccination
- Post-Exposure Prophylaxis
Global Tick Borne Encephalitis Market Size by Distribution & CAGR (2026-2033)
- Market Overview
- Government Immunization Programs
- Travel Clinics
- Hospital Pharmacies
Global Tick Borne Encephalitis Market Size by End-User & CAGR (2026-2033)
- Market Overview
- High-Risk Occupational Groups
- Travelers to Endemic Areas
Global Tick Borne Encephalitis Market Size & CAGR (2026-2033)
- North America (Product, Application, Distribution, End-User)
- US
- Canada
- Europe (Product, Application, Distribution, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product, Application, Distribution, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product, Application, Distribution, End-User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product, Application, Distribution, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Pfizer Inc. (FSME-Immun)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bavarian Nordic (Encepur)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Valneva SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi Pasteur
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sinovac Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CSL Seqirus
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bharat Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Serum Institute of India
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CanSino Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Chumakov Center (Russia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Federal Centre of Hygiene (Russia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Microgen (Russian Vaccines)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Generium Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Liaoning Cheng Da Biotechnology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sinopharm Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Walvax Biotechnology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- KM Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Daiichi Sankyo
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
